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tDITORIAL COMMENT
an Patients With Implantable
acemakers Safely Undergo
agnetic Resonance Imaging?*
. Rod Gimbel, MD, FACC,†
manuel Kanal, MD, FACR‡
noxville, Tennessee; and
ittsburgh, Pennsylvania
he controversy over whether pacemaker patients should be
llowed in the magnetic resonance imaging (MRI) suite is
ot new (1). With nearly 250 device patients reportedly
aving undergone safe magnetic resonance (MR) scanning,
ome investigators suggest selected pacemaker patients
ight safely undergo MRI (2–5). Nevertheless, many au-
horities such as Pinski and Trohman (6), flatly state that
R scanning of device patients is a “prima facia” contrain-
ication with experts like Pennel adding that such scanning
s done only on a “wing and a prayer” (7).
See page 1315
Within the context of this controversy, the study by
artin et al. (8) appears in this issue of the Journal. Notably,
mong the investigators is Shellock, an advocate of MR
afety who also quite recently stated that “the presence of a
ardiac pacemaker is considered a strict contraindication for
ndergoing an MR procedure” (9). The researchers per-
ormed a variety of MR examinations using a 1.5-Tesla (T)
agnet on 54 consecutive non–pacemaker-dependent pa-
ients having a variety of pulse generators in a mix of atrial
nd ventricular configurations. No patient experienced a
evere adverse event immediately or during the short-term
ollow-up. By design, the investigators excluded implantable
ardioverter-defibrillators (ICDs) from MR scanning. The
afety of scanning patients who, like Vice President Dick
heney, have an ICD has only recently received attention
10–12).
Safety issues of scanning patients with implanted devices,
ncluding the risk of death, have been enumerated (1,6,13).
he findings by Martin et al. (8) are consistent with
revious reports (2–5) of deliberate MRI of pacemaker
atients, with the MRI proceeding in a largely uneventful
ashion. Martin et al. (8) conclude that, if medically neces-
ary, MRI may proceed irrespective of the imaging site,
uring electrocardiographic (ECG) monitoring, and with
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Parkwest Hospital, Knoxville, Tennessee; and ‡Magnetic ResonanceMervices, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.inimal reprogramming of the device with an “acceptable
afety profile.”
Should restrictions prohibiting MRI in device patients be
ignificantly modified? Indeed, may we one day use the
ower of MR to perform scans not merely in spite of the
resence of a device, but because the patient has a device,
arnessing the power of MR to better understand issues
uch as pacing mechanics and what occurs during defibril-
ation?
Despite the encouraging results, we are concerned about
he broad conclusions and recommendations presented.
uring MRI, Martin et al. (8) recorded a variety of
henomena, all of which have been reported and reviewed
13). Understandably, the investigators concede that “the
ffects of MRI-related heating were not directly measured.”
thical and practical concerns have precluded such mea-
urements in humans.
Evaluating pacing thresholds prior to MRI and “imme-
iately upon exiting the MR system” may not detect
roblems that occur subsequently. In the Martin et al. (8)
tudy, the lack of intermediate and long-term follow-up of
he post-MRI pacing thresholds is of concern in all patients,
ut particularly in those who demonstrated a rise in thresh-
lds post-MRI. Previous scanning at 1.5-T reported un-
hanged thresholds following MRI (4,5). Concerns are
nderscored by reports of marked elevations in thresholds
fter MRI imaging of ICD systems (10,12). Given such
oncerns (14), evaluation of the pacing system beyond
immediately upon exiting the MR system” remains an
mportant need.
The results presented in Table 2 of the Martin et al. (8)
aper regarding specific absorption rate measurements and
he evaluation of “MR examinations grouped above and
elow the diaphragm” on the basis of “ease of statistical
nalysis” raise additional questions. Although the renal
rteries are “below the diaphragm,” imaging them may
eposit more radiofrequency (RF) power over the thoracic
evice than a brain scan. In this study, many scans where
ower deposition is greatest (fast-spin echo) occurred dur-
ng extremity or brain scans, where direct power deposition
n the device and leads would be far less. Additionally, the
ctual rise times and strengths of the gradients used, and
hat RF power was actually deposited on the PG system,
re entirely unknown and may be negligible (such as with
any extremity examinations). Thus, although conveniently
idy, conclusions based on the method of analysis presented
re problematic. Our understanding of these complex phe-
omena, including heating from resonant RF circuitry
ehavior, is incomplete and needs further investigation
efore clinical acceptance of the safety of these procedures.
Both the monitoring and the supervision of patients
uring MRI also raise issues. Previous reviews (6,13,14) and
rior studies of MRI (2,4,6) in device patients all included
he use of pulse oximetry in addition to ECG monitoring.artin et al. (8) acknowledge that during MRI “electro-
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Editorial Comment April 7, 2004:1325–7agnetically induced noise was encountered occasionally on
elemetry.” During MRI, the intense electromagnetic inter-
erence may render reliable assessment of the ECG quite
ifficult and often impossible. The difficulty interpreting
rtifacts is well known (15) and is seen in patients with
nsertable loop recorders undergoing MRI (16). The utility
f pulse oximetry provides additional safety, and it is
trongly recommended.
Radiologists (and MRI personnel) may be uncomfort-
ble, unwilling, or simply unable to evaluate complex,
rtifact-laden, intermittently paced rhythms during scan-
ing. Because serious dysrhythmias may occur during MRI,
t would seem advisable that a cardiologist be present in the
R suite during the entire scan and not merely “available”
r on call if needed. From a medical-legal perspective, it
ay not be hard to make a case that a more pleasant
utcome might have resulted had an “expert” been there to
mmediately manage the complications when scanning this
ontroversial patient group. The medical-legal implications
f scanning device patients are emphasized by Pinski and
rohman (6).
The reprogramming (or lack thereof) of the patient’s
acemaker prior to scanning in the Martin et al. (8) study
ives us pause. The investigators explicitly chose no device
eprogramming initially; in the end, they recommend only
inimal reprogramming prior to MR. They dismiss as
enign “magnet mode” asynchronous pacing while in the
RI suite, stating that this takes place “numerous times
during) transtelephonic pacemaker interrogation occurring
ithout incident on a daily basis.” Shellock (17) (indepen-
ently) and Goldschlager et al. (1) concur.
But is asynchronous pacing (13) always benign? A health-
er outpatient population undergoing pacemaker checks is
nlike sicker, hospitalized patients, who may not tolerate
rolonged asynchronous pacing (14). We agree “that the
isk of developing ventricular fibrillation during asynchro-
ous pacing is extremely low.” However, as with our
omments regarding monitoring and supervision, the goal is
o make scanning of patients as safe as possible, and every
ffort should be made to do so. We recommend the “magnet
ode” feature be programmed to “off,” thus avoiding
rolonged asynchronous pacing.
We believe that the researchers do not emphasize enough
he pacing features that appear in today’s devices and the
mplication for their own findings. “Over-sensing of elec-
romagnetic noise” leading to non-physiologic pacing was
oted, yet only minimal pre-MRI reprogramming is rec-
mmended. Further, we believe that features such as ven-
ricular rate regularization (Guidant Corp., St. Paul, Min-
esota), dynamic overdrive pacing (St. Jude Inc., Sylmar,
alifornia), and pacing algorithms in the Medtronic AT-
00 (Minneapolis, Minnesota) should also be disabled. The
eport of “vibration” by a patient suggests that the “rate-
esponse” feature should be turned off to avoid non-
hysiologic rapid pacing. In a non–pacemaker-dependent
atient, it is our opinion that the device should be pro-rammed in the “OOO mode or to deliver subthreshold
ulses” (6), understanding that this will not necessarily
reclude rapid cardiac pacing. Similar recommendations are
ade for MRI of patients with neurostimulators (effectively
epurposed cardiac pacemakers) by Rezai et al. (18) and
hellock himself (19), and we assume that a similar argu-
ent is valid here.
Finally, failing to identify an adverse event is not equiv-
lent to demonstrating safety—especially when only a
imited number of patients are studied. The investigators
tate: “Of note is that a recent study has identified safe
riteria for a neurostimulation system (which is a pacing
evice for the brain with bilateral leads and dual implantable
ulse generators) at 1.5-T.” However, recent reports de-
cribe serious thermal injuries from MRI of implanted leads
20,21). More extensive experience may result in a similar
ituation with cardiac devices.
Current pacemakers are neither “MRI safe” nor “MRI
ompatible” by the Food and Drug Administration’s strict
efinition (19). We believe strongly that device manufac-
urers must design their implantables as MR-compatible
from the ground up” rather than depend on a series of intrepid
atients and physicians engaged in post-manufacturing
xperiments. Patients and the implanting community
hould expect nothing less than devices that are MR-safe by
esign, not by chance.
So, is a paradigm shift occurring? Clearly, the answer is
es. In controversial matters, shifts often occur at a glacial
ace, and where patient safety is concerned, this is quite
ppropriate. In principle, we agree that non–pacemaker-
ependent patients can be scanned with an appropriate
isk-benefit ratio when appropriate care takes place before,
uring, and after MRI. But in practice, we are unconvinced
hat it matters not what type of scan is performed, nor are
e persuaded that the investigators (8) have presented the
afest way to scan device patients. Differences we highlight
re small, yet they should be viewed within the context of
he handful of device patients who died while undergoing
RI. Further, we do not believe that this controversy is
ettled simply because a handful of device patients have
afely undergone MRI. The additional measures suggested
bove will make MRI of device patients safer still. At the
resent time, if MRI procedures are performed in patients
ith pacemakers because of an overriding medical need,
hey should be approached thoughtfully and with great
aution.
eprint requests and correspondence: Dr. J. Rod Gimbel, 9330
arkwest Boulevard, Suite 202, Knoxville, Tennessee 37923.
-mail: gimbeljr@ix.netcom.com.
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